197 related articles for article (PubMed ID: 36282941)
21. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid immobilized polyacrylamide nanoparticle sensors for CD44 receptor targeting and pH measurement in cells.
Sun H; Benjaminsen RV; Almdal K; Andresen TL
Bioconjug Chem; 2012 Nov; 23(11):2247-55. PubMed ID: 23113769
[TBL] [Abstract][Full Text] [Related]
24. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
[No Abstract] [Full Text] [Related]
25. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells.
Tran TH; Choi JY; Ramasamy T; Truong DH; Nguyen CN; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2014 Dec; 114():407-415. PubMed ID: 25263908
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
Gao M; Deng H; Zhang W
Curr Top Med Chem; 2021; 21(2):126-139. PubMed ID: 32962617
[TBL] [Abstract][Full Text] [Related]
29. Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan.
Wolny PM; Banerji S; Gounou C; Brisson AR; Day AJ; Jackson DG; Richter RP
J Biol Chem; 2010 Sep; 285(39):30170-80. PubMed ID: 20663884
[TBL] [Abstract][Full Text] [Related]
30. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells.
Pramanik A; Xu Z; Ingram N; Coletta PL; Millner PA; Tyler AII; Hughes TA
Mol Pharm; 2022 Dec; 19(12):4601-4611. PubMed ID: 35938983
[TBL] [Abstract][Full Text] [Related]
32. Development of drug loaded nanoparticles for tumor targeting. Part 2: Enhancement of tumor penetration through receptor mediated transcytosis in 3D tumor models.
El-Dakdouki MH; Puré E; Huang X
Nanoscale; 2013 May; 5(9):3904-11. PubMed ID: 23549322
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone.
Sargazi A; Kamali N; Shiri F; Heidari Majd M
Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
35. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronan-coated nanoparticles for active tumor targeting: Influence of polysaccharide molecular weight on cell uptake.
Della Sala F; Silvestri T; Borzacchiello A; Mayol L; Ambrosio L; Biondi M
Colloids Surf B Biointerfaces; 2022 Feb; 210():112240. PubMed ID: 34864635
[TBL] [Abstract][Full Text] [Related]
37. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
Gu J; Chen X; Fang X; Sha X
Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
[TBL] [Abstract][Full Text] [Related]
38. Electrostatic Conjugation of Nanoparticle Surfaces with Functional Peptide Motifs.
Boehnke N; Dolph KJ; Juarez VM; Lanoha JM; Hammond PT
Bioconjug Chem; 2020 Sep; 31(9):2211-2219. PubMed ID: 32786506
[TBL] [Abstract][Full Text] [Related]
39. Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshells.
Ebbesen MF; Olesen MT; Gjelstrup MC; Pakula MM; Larsen EK; Hansen IM; Hansen PL; Mollenhauer J; Malle BM; Howard KA
Pharm Res; 2015 Apr; 32(4):1462-74. PubMed ID: 25361867
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft.
Souchek JJ; Wojtynek NE; Payne WM; Holmes MB; Dutta S; Qi B; Datta K; LaGrange CA; Mohs AM
Acta Biomater; 2018 Jul; 75():323-333. PubMed ID: 29890268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
